Business Wire

NY-INTERNATIONAL-FLAVORS

28.1.2019 22:17:06 CET | Business Wire | Press release

Share
IFF Shares 130 Years of its Storied History and Limitless Future

Regulatory News:

International Flavors & Fragrances Inc. (NYSE: IFF) (Euronext Paris: IFF) (TASE: IFF), is celebrating its 130-year anniversary with an appreciation of its past, its extraordinary people and a look to its boundless future.

IFF Chairman & CEO Andreas Fibig commented, “The incredible growth and success IFF has enjoyed through its 130-year journey didn’t happen on its own. We are the result of every win, challenge and fortune that we have experienced since our inception in the 19th century. But more than anything, it is a story best told through our people.”

From humble beginnings to IFF

On January 27, 1889, when Leopold Schwarz and Josef Polak officially turned their kitchen table startup into Polak & Schwarz (P&S), it is a safe bet that they couldn’t imagine what this fledgling company would become. Mr. Schwarz was simply following a passion for spices and essences, moving from the bakery ingredients sales job he’d begun as a teenager. But under their capable hands, P&S grew.

Fast-forward to 1917. Mr. Polak left the young company, but Mr. Schwarz persevered. He established P&S in many countries, but set his sights opening an office in the United States. As IFF folklore states, the “enterprising Dutchman,” Arnold Louis van Ameringen was hired to open P&S’s first US facility. Shortly after Mr. van Ameringen’s arrival in the US, P&S let him go. Undaunted, he quickly established van Ameringen & Co., selling both flavors and fragrances. Both companies prospered.

In 1958, Mr. van Ameringen shared the news that his company, evolved into van Ameringen-Haebler, and Polak & Schwarz, would merge to become International Flavors & Fragrances Inc., with him as president. The irony of helming the company that fired him 41 years earlier was never lost on him.

Our People

“One of the hallmarks of IFF and its predecessor companies has been the passion of its people,” said IFF Chairman & CEO Andreas Fibig. “Throughout our history, we have been fortunate to share our lives with some truly spectacular colleagues – people unafraid to speak their mind, to turn dreams to reality, or to buck convention. We embrace these changemakers. They have shaped our company and the world.”

Take Dr. Braja Mookherjee, for example. An IFFer for 38 years, he was a scientist with the soul of an artist. He embodied everything IFF strives for and his impact on the flavors and fragrances industry reached much further than the greenhouse he ran. He dreamed big – all the way to outer space – and pondered the effect of microgravity on the aroma molecules of a living rose. On October 29, 1998, his “Overnight Sensation,” a miniature rose plant, became the most famous payload aboard the NASA Space Shuttle mission STS-95, while IFF monitored the control plant back on earth. The findings showed that the three major chemical components of the flower changed dramatically in microgravity; causing a difference in fragrance. "This transformation has created a completely new fragrance that is not of this earth," he stated. His spirit of discovery and innovation lives on at IFF.

Our story continues…

“IFF has changed and reinvented itself many times over its 130 years, but the past five years has seen its biggest shift to date,” continued Mr. Fibig. “With an unprecedented innovation pipeline and the acquisition of Frutarom, we are a new company yet again. The magnitude of our talent, the increase in our portfolio and offerings to our customers, and our expanded geographical and customer reach is unparalleled in our history.”

“Our story continues to unfold and I have never been more optimistic about our future,” Mr. Fibig concluded. “I want to recognize every IFFer that made this great company their passion. I honor our past leaders for rising to extraordinary challenges and taking the right risks. I thank our customers, big and small, for their partnership and shared vision. IFF is what it is today because of the relationships we’ve forged through good times and challenging ones, from the risks we’ve undertaken and those thrust upon us. We wear our age, history and our scars with pride and I know they make us stronger and more confident about our future than ever.”

# # #

Meet IFF

International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris: IFF) (TASE: IFF) is a leading innovator of scent, taste, and nutrition, with over 110 manufacturing facilities, 100 R&D centers, and 33,000 customers globally. At the heart of our company, we are fueled by a sense of discovery, constantly asking “what if?”. That passion for exploration drives us to co-create unique products that consumers experience in more than 150,000 unique products sold annually. Our 13,000 team members globally take advantage of leading consumer insights, naturals exploration, research and development, creative expertise, and customer intimacy to develop differentiated offerings for consumer products.

Learn more at www.iff.com , Twitter , Facebook , Instagram , and LinkedIn .

Contact:

International Flavors & Fragrances Inc. Michael DeVeau Head of Investor Relations and Communications & Divisional CFO, Scent 212.708.7164 Michael.DeVeau@iff.com

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Vertex Presents New Data on ALYFTREK® at European Cystic Fibrosis Conference5.6.2026 18:00:00 CEST | Press release

- ALYFTREK Phase 3 data on children with cystic fibrosis ages 2 to 5 with vanzacaftor/tezacaftor/deutivacaftor-responsive genotypes including F/F and F/MF shows 65% reached sweat chloride levels of <30 mmol/L; Vertex on track to initiate global regulatory submissions in first half of 2026 - - Long-term 96-week interim analyses from two open-label extension studies demonstrate positive safety and efficacy profile of ALYFTREK in people with cystic fibrosis ages 6 and older -- Phase 3 data on TRIKAFTA® in children 1 to <2 years also presented; Vertex has initiated global regulatory submissions - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data demonstrating the potentially transformative impact of treating cystic fibrosis (CF) with ALYFTREK ® (vanzacaftor/tezacaftor/deutivacaftor) in children ages 2 to 5, as well as data from 96-week interim analyses of two open-label extension studies of ALYFTREK in children 6 to 11 years and people 12 years and older demonstrating

Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi5.6.2026 13:00:00 CEST | Press release

Owkin, the agentic AI company pioneering Biological Artificial Superintelligence to transform drug discovery and development, today announced a multi-year collaboration with Sanofi to co-develop next-generation biopharma agents, to be backed by a five-year license for K Pro, Owkin’s AI Scientist. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260605704506/en/ K Pro, Owkin's AI scientist for biology, powered by multimodal patient data for smarter biopharma decision making. Owkin and Sanofi have collaborated since 2021 through a €90 million strategic partnership focused on target identification in oncology and patient subgrouping. The collaboration was later expanded to include drug positioning for Sanofi’s immunology pipeline. This new collaboration represents the next evolution in the partnership. During the five-year collaboration, Owkin will lead the end-to-end development of novel AI-driven biopharma agents purpose-built

DFNS Rebrands as the Core Banking Platform for Digital Assets5.6.2026 12:41:00 CEST | Press release

DFNS today announced a rebrand, marking its evolution from a wallet infrastructure to the first core banking platform for digital assets. The company is introducing a new logo, website, and market position as fintechs and institutions move their products and operations onchain. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260603859127/en/ Banks, fintechs, asset managers, trading firms, payment providers, market infrastructures, and clearing houses have stopped asking how to "add crypto." They're asking how to run financial products, controls, workflows, and client services on blockchain rails, with the reliability expected of core infrastructure. Some are going further still, exploring whether the blockchain can serve as the ledger itself, where an account is an onchain object rather than a row in a database. Where IBANs, virtual accounts, and blockchain wallets converge into one governed financial account. “DFNS was built

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.6.2026 12:30:00 CEST | Press release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to seventeen newly hired non-executive employees. The equity awards were granted on June 1, 2026 and consisted of options to purchase an aggregate of 157,000 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 74,700 shares. The options have an exercise price per share equal to $14.19, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restrict

Renewable Electricity, Soft Wheat Flour From Regenerative Agriculture, Initiatives to Support Local Communities: Barilla Shares These and Other Projects in “Stories of Sustainability.”5.6.2026 10:00:00 CEST | Press release

Barilla continues to advance its commitment to tastier products with less sugar and salt;An investment of 30 million euros in 2025 to quadruple photovoltaic capacity across plants, as part of a €168 million five-year plan focused on energy efficiency, renewable energy and sustainable water management.Barilla continues to expand regenerative agriculture practices across its global value chain, with over 816,000 tons of raw materials sourced through the Barilla Sustainable Farming program.4,000 tons of products donated worldwide and €2 million allocated to social causes in 2025, supporting communities across Barilla’s global footprint through food donations and social initiatives. A slimmer Tagliatelle pack that saves 150 tons of cardboard and cuts transport-related CO₂ emissions by 20%1; ready-made sauce jars made with around 65% recycled glass; the progressive scaling of regenerative agriculture practices across Barilla’s value chain and initiatives supporting inclusion and equal oppor

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye